ESC Premium Access

Baseline hemodynamics and its effect on survival in patients with idiopathic versus CTD-associated pulmonary arterial hypertension: data from the Swedish Pulmonary Arterial Hypertension Register

Presentation

About the speaker

Associate Professor Clara Hjalmarsson

Sahlgrenska University Hospital, Department of Internal Medicine, Gothenburg (Sweden)
0 follower

10 more presentations in this session

Efficacy of the novel thromboxane receptor antagonist NTP42 alone, or in combination with Sildenafil, in the sugen/hypoxia-induced model of pulmonary arterial hypertension

Speaker: Professor T. Kinsella (Dublin, IE)

Thumbnail

Selexipag dosing and titration in the first 500 patients enrolled in SPHERE (SelexiPag: tHe UsErs dRug rEgistry)

Speaker: Professor V. McLaughlin (Ann Arbor, US)

Thumbnail

Effects of inhaled nitrite in addition to sildenafil in thalassemia patients with pulmonary hypertension

Speaker: Doctor T. Sasiprapha (Bangkok, TH)

Thumbnail

Electroanatomical mapping of right atrium in patients with pulmonary hypertension

Speaker: Doctor Z. Fingrova (Prague, CZ)

Thumbnail

Patient characteristics and treatment patterns in the multicentre, retrospective chart review of first-time Opsumit (macitentan) users in the United States (OrPHeUS)

Speaker: Professor V. McLaughlin (Ann Arbor, US)

Thumbnail

Access the full session

Poster Session 4 - Pulmonary arterial hypertension - Treatments

Speakers: Associate Professor C. Hjalmarsson, Professor T. Kinsella, Professor V. McLaughlin, Doctor T. Sasiprapha, Doctor Z. Fingrova...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk